No Medicare policies identified
In the absence of a LCD, NCD, billing and coding article or CMS manual instruction, NCCI or MUE, reasonable and necessary...
Articles
Article Type
Category
Reporting the national drug code
Read this article for helpful information to report the national drug code on claims.
Billing for Rebyota fecal microbiota, live-jslm, HCPCS code J1440 -- Avoid rejections
Previous instructions to bill Rebyota fecal microbiota, live-jslm with HCPCS G0455, expired effective June 30, 2023. Instead...
Bill infectious disease panels correctly
First Coast identified several errors when providers bill for infectious disease panels. Read this article to learn more about...
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated...
Clinical trials background
Medicare covers the routine costs of qualifying clinical trials, as such costs are defined in National Coverage Determination...
Open meeting fact sheet
The purpose of the open meeting is to allow interested parties the opportunity to make presentations of information and offer...
Contractor Advisory Committee (CAC) meeting fact sheet
The CAC is used to supplement the MAC’s internal expertise and to ensure an unbiased and contemporary consideration of “state of...
Submission of new drug information
First Coast accepts information regarding new drugs, new or revised indications, or marketing materials for forthcoming drugs or...
Transcatheter aortic valve replacement (TAVR)
Important information notifying users of the requirements for approval of transcatheter aortic valve replacement (TAVR) studies.